Literature DB >> 21607751

Cancer-immune equilibrium: questions unanswered.

Alka Bhatia1, Yashwant Kumar.   

Abstract

Cancer-immune (CI) equilibrium constitutes an important component of the cancer immunoediting theory. It is defined as a period during which our immune system and cancer live in harmony in the body. The immune system, though not able to completely eliminate the cancer, doesn't allow it to progress or metastasize further. Mechanisms of this phase are poorly understood because this phase is difficult to identify even by the most modern detection methods. Till now, the work done on the equilibrium phase of cancer, suggests promising improvements in cancer therapy if the disease could be withheld in this phase. However, there are many queries which remain to be addressed about this interesting yet unresolved phase of cancer immunity.

Entities:  

Year:  2011        PMID: 21607751      PMCID: PMC3170416          DOI: 10.1007/s12307-011-0065-8

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  56 in total

1.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery.

Authors:  Rona M MacKie; Robin Reid; Brian Junor
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  The capacity of the immune system to control cancer.

Authors:  Leif Håkansson
Journal:  Eur J Cancer       Date:  2009-07-14       Impact factor: 9.162

3.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

Review 4.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

5.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

6.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

Review 7.  Immune-mediated dormancy: an equilibrium with cancer.

Authors:  Michele W L Teng; Jeremy B Swann; Catherine M Koebel; Robert D Schreiber; Mark J Smyth
Journal:  J Leukoc Biol       Date:  2008-05-30       Impact factor: 4.962

Review 8.  Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.

Authors:  Elena Favaro; Alberto Amadori; Stefano Indraccolo
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

9.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

10.  Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.

Authors:  Ping Yu; Youjin Lee; Wenhua Liu; Thomas Krausz; Anita Chong; Hans Schreiber; Yang-Xin Fu
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  16 in total

Review 1.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression.

Authors:  Pedro A C Costa; Walison N Silva; Pedro H D M Prazeres; Caroline C Picoli; Gabriela D A Guardia; Alinne C Costa; Mariana A Oliveira; Pedro P G Guimarães; Ricardo Gonçalves; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Rodrigo R Resende; Remo C Russo; Thiago M Cunha; Pedro A F Galante; Akiva Mintz; Alexander Birbrair
Journal:  Acta Neuropathol Commun       Date:  2021-11-16       Impact factor: 7.801

3.  Tissue-resident glial cells associate with tumoral vasculature and promote cancer progression.

Authors:  Beatriz G S Rocha; Caroline C Picoli; Bryan O P Gonçalves; Walison N Silva; Alinne C Costa; Michele M Moraes; Pedro A C Costa; Gabryella S P Santos; Milla R Almeida; Luciana M Silva; Youvika Singh; Marcelo Falchetti; Gabriela D A Guardia; Pedro P G Guimarães; Remo C Russo; Rodrigo R Resende; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Alexandre Kanashiro; Helder I Nakaya; Edroaldo L Rocha; Pedro A F Galante; Akiva Mintz; Paul S Frenette; Alexander Birbrair
Journal:  Angiogenesis       Date:  2022-10-01       Impact factor: 10.658

4.  Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies.

Authors:  Bo Yuan; Linlin Miao; Disen Mei; Lingzhi Li; Qiongyan Zhou; Dong Dong; Songting Wang; Xiaoxia Zhu; Suling Xu
Journal:  Comput Math Methods Med       Date:  2022-06-20       Impact factor: 2.809

Review 5.  Advances and challenges: dendritic cell vaccination strategies for glioblastoma.

Authors:  Teilo H Schaller; John H Sampson
Journal:  Expert Rev Vaccines       Date:  2016-08-10       Impact factor: 5.217

6.  Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.

Authors:  Mingyang Lu; Bin Huang; Samir M Hanash; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 7.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

Review 8.  Immune system and melanoma biology: a balance between immunosurveillance and immune escape.

Authors:  Anna Passarelli; Francesco Mannavola; Luigia Stefania Stucci; Marco Tucci; Francesco Silvestris
Journal:  Oncotarget       Date:  2017-10-31

Review 9.  Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.

Authors:  Jiangang Zhao; Jiahui Li; Hans A Schlößer; Felix Popp; Marie Christine Popp; Hakan Alakus; Karl-Walter Jauch; Christiane J Bruns; Yue Zhao
Journal:  Stem Cells Int       Date:  2017-08-06       Impact factor: 5.443

Review 10.  Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.

Authors:  Veronica Romano; Immacolata Belviso; Alessandro Venuta; Maria Rosaria Ruocco; Stefania Masone; Federica Aliotta; Giuseppe Fiume; Stefania Montagnani; Angelica Avagliano; Alessandro Arcucci
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.